Westmead Institute for Cancer Research
The ACRF grant enabled the construction of a dedicated new laboratory wing for Westmead Institute of Cancer Research in the planned Westmead Millennium Institute building. The aim of the new institute was to consolidate all WICR units into one new building to ease the overcrowding and to increase collaboration between researchers.
The consolidation of all WICR units in the new Westmead Millennium Institute building created a distinct, readily identifiable identity and physical presence that increases cross-discipline collaboration, fosters efficiency and helps achieve positive health outcomes.
The central hypothesis linking WICR research is that advances in the prevention and treatment of cancer will be achieved through the identification and characterisation of the molecular and cellular basis of common forms of this disease.
WICR’s research program is closely integrated with the clinical cancer services of Westmead Hospital, and therefore has a strong emphasis on human models, cancer types common in Australia and on translational outcomes.
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialed for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.